Entity > Corporation > US > New York City New York > Curis

About Curis

Curis, Inc. is a biotechnology company focused on the development of first-in-class and innovative therapeutics for the treatment of cancer.

Curis, Inc. Has Three Drug Candidates in Development: Emavusertib (CA-4948), an orally-available, small molecule inhibitor of the IRAK4 kinase.

CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation.

Fimepinostat, an orally available, small molecule inhibitor of HDAC and PI3K enzymes.

Curis, Inc. Is in Collaboration With Aurigene: Curis is engaged in a collaboration with Aurigene for discovery and development of drug candidates in the area of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule dual antagonists of PD1 and VISTA, including PDL1/VISTA antagonist CA-170, and oral small molecule dual antagonists of PD1 and TIM3, including PDL1/TIM3 antagonist CA-327, as well as to molecules designed to inhibit the IRAK4 kinase, including CA-4948.

Collaborators at Curis: The Company's collaborators, F. Hoffmann-La Roche Ltd, or Roche, and Genentech Inc., or Genentech, a member of the Roche Group, are commercializing Erivedge®(vismodegib) for the treatment of patients with advanced basal cell carcinoma, or BCC.

The Curis Mission: Working relentlessly to develop innovative and differentiated therapeutics that improve the lives of cancer patients.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Curis

Company Attribute Value
Address StreetAddress: 128 Spring St Ste 500, AddressLocality: Lexington, AddressRegion: Massachusetts, PostalCode: 2421, AddressCountry: United States
Founding Date 2000
Name Curis
Number Of Employees 42
Revenue $10,624,000 USD
Ticker Symbol NASDAQ: CRIS
Url curis
Linkedin linkedin
Twitter twitter
Google google



New York City, US
18 Feb 2024

New York City, US
18 Feb 2024


Page: 1 Desktop | Laptop Devices
Curis, Inc: Home
CURIS › quote › CRIS
Curis, Inc. (CRIS) Stock Price, News, Quote & History
Curis, Inc. (@CurisInc) / X
Places / GMB
Places / GMB
Curis Medical PLLC › ... › Stocks › United States
Curis Inc. Stock Quote (U.S.: Nasdaq) - CRIS › quotes › CRIS
CRIS: Curis Inc - Stock Price, Quote and News
Related Searches
Related Searches
Curis medicine
curis buyout
Curis pharma
Knowledge Panel
Knowledge Panel

Curis, Inc. (Biotechnology company)

  • Stock price : CRIS (NASDAQ) $10.49 +0.27 (+2.64%)Feb 16, 4:00 PM EST - Disclaimer
  • Headquarters : Lexington, MA
  • Founded : 2000

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 193809